Puretech Health Plc Stock Performance

PTCHF Stock  USD 1.85  0.12  6.94%   
PureTech Health has a performance score of 8 on a scale of 0 to 100. The company holds a Beta of 0.0163, which implies not very significant fluctuations relative to the market. As returns on the market increase, PureTech Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding PureTech Health is expected to be smaller as well. PureTech Health plc right now holds a risk of 1.68%. Please check PureTech Health plc kurtosis, as well as the relationship between the day median price and period momentum indicator , to decide if PureTech Health plc will be following its historical price patterns.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in PureTech Health plc are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical indicators, PureTech Health may actually be approaching a critical reversion point that can send shares even higher in February 2026. ...more
Begin Period Cash Flow403.9 M
Total Cashflows From Investing Activities197.4 M
  

PureTech Health Relative Risk vs. Return Landscape

If you would invest  168.00  in PureTech Health plc on October 29, 2025 and sell it today you would earn a total of  17.00  from holding PureTech Health plc or generate 10.12% return on investment over 90 days. PureTech Health plc is currently producing 0.1747% returns and takes up 1.6839% volatility of returns over 90 trading days. Put another way, 15% of traded pink sheets are less volatile than PureTech, and 97% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon PureTech Health is expected to generate 2.25 times more return on investment than the market. However, the company is 2.25 times more volatile than its market benchmark. It trades about 0.1 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.09 per unit of risk.

PureTech Health Target Price Odds to finish over Current Price

The tendency of PureTech Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 1.85 90 days 1.85 
near 1
Based on a normal probability distribution, the odds of PureTech Health to move above the current price in 90 days from now is near 1 (This PureTech Health plc probability density function shows the probability of PureTech Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon PureTech Health has a beta of 0.0163 indicating as returns on the market go up, PureTech Health average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding PureTech Health plc will be expected to be much smaller as well. Additionally PureTech Health plc has an alpha of 0.1477, implying that it can generate a 0.15 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   PureTech Health Price Density   
       Price  

Predictive Modules for PureTech Health

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as PureTech Health plc. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.181.853.52
Details
Intrinsic
Valuation
LowRealHigh
0.512.183.85
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as PureTech Health. Your research has to be compared to or analyzed against PureTech Health's peers to derive any actionable benefits. When done correctly, PureTech Health's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in PureTech Health plc.

PureTech Health Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. PureTech Health is not an exception. The market had few large corrections towards the PureTech Health's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold PureTech Health plc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of PureTech Health within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.15
β
Beta against Dow Jones0.02
σ
Overall volatility
0.05
Ir
Information ratio 0.05

PureTech Health Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of PureTech Health for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for PureTech Health plc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
PureTech Health plc may become a speculative penny stock
The company reported the revenue of 9.98 M. Net Loss for the year was (60.56 M) with profit before overhead, payroll, taxes, and interest of 17.39 M.
PureTech Health plc has accumulated about 368.03 M in cash with (158.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.28.
Roughly 72.0% of the company shares are owned by institutional investors

PureTech Health Fundamentals Growth

PureTech Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of PureTech Health, and PureTech Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PureTech Pink Sheet performance.

About PureTech Health Performance

By analyzing PureTech Health's fundamental ratios, stakeholders can gain valuable insights into PureTech Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if PureTech Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if PureTech Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts. PURETECH HEALTH operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 95 people.

Things to note about PureTech Health plc performance evaluation

Checking the ongoing alerts about PureTech Health for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for PureTech Health plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
PureTech Health plc may become a speculative penny stock
The company reported the revenue of 9.98 M. Net Loss for the year was (60.56 M) with profit before overhead, payroll, taxes, and interest of 17.39 M.
PureTech Health plc has accumulated about 368.03 M in cash with (158.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.28.
Roughly 72.0% of the company shares are owned by institutional investors
Evaluating PureTech Health's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate PureTech Health's pink sheet performance include:
  • Analyzing PureTech Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PureTech Health's stock is overvalued or undervalued compared to its peers.
  • Examining PureTech Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating PureTech Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of PureTech Health's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of PureTech Health's pink sheet. These opinions can provide insight into PureTech Health's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating PureTech Health's pink sheet performance is not an exact science, and many factors can impact PureTech Health's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for PureTech Pink Sheet analysis

When running PureTech Health's price analysis, check to measure PureTech Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PureTech Health is operating at the current time. Most of PureTech Health's value examination focuses on studying past and present price action to predict the probability of PureTech Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PureTech Health's price. Additionally, you may evaluate how the addition of PureTech Health to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Commodity Directory
Find actively traded commodities issued by global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity